AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · United States

HB7091

Expanding Veterans’ Access to Emerging Treatments Act

Status

Pending

2026 Session

IntroducedJan 15, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Jack Bergman (Republican)
Type: Clinical Research
Substances: Psilocybin

Official text

Summary (from PoliPsy)

To direct the Secretary of Veterans Affairs to establish an investigational research and extended access treatment program utilizing innovative treatments and emerging therapies to address conditions with unmet medical needs, and for other purposes.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: congress.gov

Legislative history

February 2, 2026
Referred
February 2, 2026
Referred
January 15, 2026
Referred
January 15, 2026
Introduced

Loading bill…